Paysign, Inc. (PAYS) director exercises 20,000-share grant, now holds 90,000
Rhea-AI Filing Summary
Paysign, Inc. director Jeffrey B. Newman exercised a stock grant, converting 20,000 derivative shares into 20,000 shares of common stock on August 04, 2026. The underlying grant for 20,000 shares was awarded on August 04, 2025 and fully vested by the filing date. Following the transaction he directly owned 90,000 shares of Paysign common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 20,000 shares
Net Buy
2 txns
Insider
NEWMAN JEFFREY B
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Grant F1 | 20,000 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 20,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Grant — 0 shares (Direct);
Common Stock — 90,000 shares (Direct)
Footnotes (1)
- F1. On August 04, 2025, the reporting person received a grant of 20,000 shares of common stock vesting on August 04, 2026. As of the date of this filing, 20,000 shares of common stock have vested.
Key Figures
Shares underlying stock grant: 20,000 shares
Shares acquired via exercise: 20,000 shares
Exercise price per share: $0.0000
+3 more
6 metrics
Shares underlying stock grant
20,000 shares
Size of Stock Grant reported as derivative security
Shares acquired via exercise
20,000 shares
Common Stock acquired on 2026-08-04 through derivative exercise
Exercise price per share
$0.0000
Reported transaction price per share for the derivative exercise
Shares owned after transaction
90,000 shares
Direct Paysign common shares held by Jeffrey B. Newman after the Form 4 transactions
Grant award date
August 04, 2025
Date the 20,000-share common stock grant was received
Grant vesting date
August 04, 2026
Date on which the 20,000-share grant vested
Key Terms
derivative security, Stock Grant, vested, Rule 10b5-1 trading plan
4 terms
derivative security financial
"transaction_code_description: Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
Stock Grant financial
"security_title: Stock Grant with 20,000 underlying common shares"
A stock grant is an award of company shares given to an individual, often as part of compensation for employees or executives. It matters to investors because grants can change the number of shares outstanding (dilution) and signal how company leaders are being paid and motivated—think of it like receiving a slice of the company as part of your paycheck, which can affect ownership and future share supply.
vested financial
"20,000 shares of common stock have vested as of the date of this filing"
Rule 10b5-1 trading plan regulatory
"The filing does not identify the transactions as made under a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did Paysign (PAYS) director Jeffrey B. Newman report?
Jeffrey B. Newman reported exercising a stock grant covering 20,000 shares, converting it into 20,000 shares of Paysign common stock. The transaction is coded as an exercise or conversion of a derivative security (code M) with no open-market sale or purchase reported.
When was Jeffrey B. Newman’s Paysign (PAYS) stock grant awarded and when did it vest?
The grant of 20,000 shares of Paysign common stock was awarded on August 04, 2025, vesting on August 04, 2026. The footnote states that, as of the filing date, all 20,000 shares under this grant had vested.
Was the Paysign (PAYS) Form 4 transaction made under a Rule 10b5-1 plan?
The filing does not identify the transactions as made under a Rule 10b5-1 trading plan. The document-level 10b5-1 checkbox is not marked and the footnote describing the grant and vesting contains no reference to any such trading arrangement.